News Item
Center for Molecular Medicine Named a Top Innovation for 2008 by the West Michigan Business Review
21 August 08
On Thursday, July 17, 2008, the Center for Molecular Medicine was named a top innovation in West Michigan by the Business Review. For the past three years, Business Review has recognized area companies or organizations for their “innovative” products or services. CMM was one of nine companies honored and was recognized for its innovative capabilities and cutting-edge diagnostic services it brings to West Michigan.
The nine winners were chosen among 35 finalists and were recognized for ingenuity, positive impact on the region, timeliness and for exceeding their peer’s expectations.
The event was held at Grand Valley State University’s Pew Campus and attracted nearly 300 attendees. For more information about Innovation Michigan and the Business Review, visit www.mbusinessreview.com.
The SCMM offers physicians and their patients FDA-approved microarray based tests to examine genotypes. Our menu of services is constantly growing.
The SCMM offers IVD, biotech and pharmaceutical companies cost-effective microarray analysis on pre-clinical samples in a CLIA-certified laboratory environment. The SCMM is also CAP accredited and GLP-like environment.
© Copyright 2008 Sequenom Center for Molecular Medicine